Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMEDECS is a healthcare services company focused on independent medical review rather than drug development. The business provides URAC-accredited peer review, external appeals, and dispute resolution services to health plans and other healthcare stakeholders. IMEDECS built a reputation as an independent review organization with a national network of physician reviewers and expertise in quality-of-care and coverage determinations. In May 2021, Kepro acquired substantially all of the assets of Independent Medical Expert Consulting Services, and the IMEDECS business has since operated as an independent medical review division within the acquirer’s organization, now associated with Acentra Health.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMEDECS.